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Purpose: The Seattle Heart Failure Model (SHFM), the Interagency
Registry for Mechanically Assisted Circulatory Support (INTERMACS) and
the Index for Mortality Prediction After Cardiac Transplantation (IMPACT)
score are newly used in heart transplantation for graft allocation. We aimed if
these scores could be useful in risk stratification for cardiac transplantation in
our center. 
Methods: The SHFM, the INTERMACS model and the IMPACT score
were retrospectively calculated for 182 heart transplantation candidates
and 152 non-VAD patients who underwent urgent and non-urgent heart
transplantation between January 2004 and April 2013 in our center.
Results were compared with actual mortality at 1, 2 and 5 years. The per-
formance of these score in predicting hospital mortality was evaluated
with ROC curve.
Results: Predicted mortality at 1, 2 and 5 years with the SHFM score
was significantly higher (p<0.001) in patients who required urgent trans-
plantation. This score was not efficient for predicting waiting list mortality
(AUC= 0,70). A trend toward higher post-transplant mortality at 1, 2 and
5 years was observed in the 1 to 3 INTERMACS class. All patients with
INTERMACS I profile dead after heart transplantation. The IMPACT score
was not efficient in predicting post transplantation mortality in our popula-
tion (AUC = 0,56).
Conclusion: The SHFM should be used to discriminate patients on waiting
list and discuss the degree of required priority. The INTERMACS classifica-
tion appears to be promising tools for heart recipient selection. IMPACT score
seems not adapted to in our population.
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Background: KaRen is a prospective study designed to characterize and
follow a cohort of heart failure with preserved ejection fraction (HFpEF)
patients. HFpEF remains a challenging syndrome. Patients have clinical signs
linked to congestion but left ventricular (LV) EF is > 45%. We sought to test
the relevance of echocardiographic parameters as predictors of death or hospi-
talization for cardiovascular reasons.
Methods and results: Following an acute HF accompanied with NT-
proBNP >300 pg/mL (BNP >100 pg/mL) and LVEF >45%, patients were
included (n=349). The patients were reassessed by echo-Doppler after 4-8
weeks. Echocardiographies were standardized and the analysis centralized.
LVEF was 62±13%, LV global longitudinal strain: – 15±3%, E/e’:12.9±6.2,
Left atrial volume: 49±18ml/m², Tricuspid regurgitation: 2.9±0.9m/s. Two
parameters are correlated with the survival without any death or hospitalisa-
tion for cardiovascular reason and could be combined in a score: 2 x (E / e’)
+ RA area. This score has a theoretical range between 0 and 14. Based on ter-
tiles of the score, censoring (frequencies of death or hospitalization for heart
failure) were 48 (37.80), 67 (57.76) and 85 (75.22) in the 1st tertile – poor
prognosis (N = 127), the 2nd tertile – intermediate (N = 116) and the 3rd ter-
tile – good prognosis (N = 113), respectively.
Conclusion: Combination of simple echocardiographic criteria (right atrial
area and E/e’ ratio) was found relevant to predict the long term prognosis in
a large cohort of patients diagnosed for heart failure with preserved ejection
fraction. 
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Friedreich Ataxia (FRDA) is an autosomal recessive cerebellar ataxia,
caused by GAA expansion in frataxin gene. Hypertrophic cardiomyopathy is
usual in FRDA and cardiac complications are the first cause of death. From
1990 to 2012, we studied 141 patients with genetically confirmed FRDA.
Mean age was 30±10y (mean±sd), 54% were female, age at onset 16±8y,
disease duration 15±8y and 74% were wheelchair users.Mean length of short
GAA expansion was 1,85±0,7Kb and of longer allele 2.6±0.7Kb.Each
patient underwent clinical examination, electrocardiogram and echocardiog-
raphy. 9% had chest pain, 2,8% dyspnea and 9% palpitations. ECG pre-
sented T wave abnormalities (88%). 3 patients had atrial fibrillation
(AF).LV interventricular septal wall thickness (IVS) was 12±3mm, LV pos-
terior wall thickness (PW) =11±2mm, LV diastolic diameter (EDD) =
43±5mm, LV systolic diameter (ESD) =25±5mm and indexed LV mass
(LVMi) =103±31g/m², LV ejection fraction (EF) = 67±7%. News were
obtained in 2013, no patient was lost of follow-up. After a median follow up
of 12±5y, 16 deaths occurred and 1 patient was transplanted (38±10y).
26 patients (18%) experienced AF (34±10y), 14 (10%) heart failure
(36±12y) and 15 (11%) had EF<50% (33±11y). In univariate analysis, the
predictors of survival were: short GAA (p<0.0001), age of onset (p=0.0002),
ESD (p=0.002), IVS (p=0.0087), EF (p=0.0001) and LVMi (p=0.01). In
multivariate analysis, only short GAA (p=0.001), EF (p=0.01) and LVMi
(p=0.008) were independent predictors of survival. Short GAA and LVMi
remained independent predictors of the first cardiac events in multivariate
analysis (p=0.0002, and p=0.0003 respectively). GAA repeats are the best
predictors of survival and cardiac events in FRDA patients, but EF and LV
mass are also predictors of long term evolution suggesting the importance of
cardiac management in Friedreich ataxia.
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Cardiac amyloidosis (CA) is of poor prognosis and has three main causes:
light chain (AL), hereditary (m-TTR) and wild type transthyretin amyloidosis
(WT-TTR). Longitudinal 2D-strain (LS) has been proposed for early diagnosis
of AL-CA with increased LS, indicating less contractility, in basal segments.
LS apical sparing physiopathology and prognosis value are unknown in the
3 types of CA. 
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Aims: 1-Compare regional LV LS between the 3 types of CA, 2 – Deter-
mine if they correlate to amyloid deposits; 3 – Determine the prognostic value
of LV LS.
Methods: 79 patients were prospectively included. 17 segments LV LS
was measured. 53 had cardiac MRI with LGE evaluation for each segment.
Amyloid deposition was quantified using Congo red staining in the
3 explanted heart following heart transplant (HT). All patients were followed-
up. The composite primary endpoint was major adverse cardiac event
(MACE) i.e., death, HT, and acute heart failure. MACE predictors were iden-
tified by multivariate analysis.
Results: 26 patients had AL, 36 m-TTR and 17 WT-TTR CA. Global
(–10±4%) and regional 17 LV LS were similarly impaired in the 3 types of
CA. 91% of MRI had LV LGE enhancement. Both LGE and LS analysis
showed a basal to apex gradient. Interestingly LS in the basal free wall (mean
– 5±6%) had the best accuracy to predict LGE (AUC=0.97, P=0.002; 95%CI
{0.92-0.99}). Amyloid deposits in the 3 HT were more frequent in the basal
segments and a strong correlation was found between LGE and LS segments
(r=0.72). 46% experienced MACE during the follow-up with median of
13[7;23] months for survivors. Apical LS, NT-proBNP and NYHA III-IV
were independently associated with MACE. Cut-off to predict MACE was
–14.5% for Apical LS and 4000ng/L for NT-proBNP.
Conclusions: LS abnormalities are similar between CA types and reflect
amyloid deposition which predominates in basal LV segments. Impairment of
basal free wall LS predict LV MRI LGE. High value of apical LS is an inde-
pendent predictor of MACE.
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Background: Accuracy of 99mTc-HMDP scintigraphy (sHMDP) to diag-
nose cardiac amyloidosis (CA) and to discriminate between the different eti-
ologies i.e hereditary TTR amyloidosis (hTTR), senile amyloidosis (wt-TTR)
and light chain amyloidosis (AL) are unknown.
Methods: 122 patients referred for suspected CA were prospectively
studied with sHMDP. HMDP fixation was evaluated by a visual score
(0 up to 3). Heart-to-whole-body (H/WB) and heart-to-skull (H/S) ratio
were calculated on planar images. Diagnosis of amyloidosis was biopsy
proven for all AL. Diagnosis of CA for hTTR and wt-TTR was established
by an experts consensus based on echocardiography, cardiac MRI (cardiac
wall thickness ≥12mm), genetic testing and biopsy whenever ethically
possible.
Results: The mean age was 69 (59; 78), 71% were men; of whom, 14
(11%) were considered having AL, 34 (28%) hTTR, 21 (17%) wt-TTR and 53
(43%) had cardiac hypertrophy from other causes. Of the 61 (50%) patients
with CA, 46 (75%) had a HMDP visual scoring ≥1; of whom 1/14 (7%) had
AL, 24/26 (92%) hTTR and 21/21 (100%) wt-TTR.
Cardiac HMPD uptake was absent among all patients without CA (n=61).
Visual score was stronger in TTR-CA versus AL-CA (p<0.0001). A visual
score ≥2 to diagnose TTR-CA had a predictive positive value of 100%.
Among CA, H/WB and H/S ratio were significantly higher (p <0.002) in both
hTTR (H/WB=3.92±0.93 H/S=2.26±0.98) and wt-TTR (H/WB=4.36±0.95 H/
S=2.86±1.12) versus AL (H/WB=2.67±0.61; H/S=1.70±1.53). Eleven patients
with myocardial 99mTc-HDPD uptake underwent a second sHMDP with a
median (25th; 75th) of 15.1 months (7.3; 16.2) of whom two had an increase in
visual score and H/WB ratio. (Image 1, next page) 
Conclusion: 99mTc-HMDP scintigraphy is a useful tool to diagnose CA,
define its etiology and might be useful for follow-up. 
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The incidence of sudden cardiac death (SCD) increases with age in parallel
with coronary’s diseases’ prevalence. In young persons and athletes, SCD
occurs in half of the cases, in the setting of genetically transmitted disorders
such as cardiomyopathies. Molecular testing performed after necropsy may
help management of families but experience in this area appears very limited.
The aim is to report our experience of post mortem molecular testing after
SCD and necropsy. We studied 36 patients <40 years who died suddenly with
a suspected diagnosis of cardiomyopathy, established either after autopsy or
known before death , with 6 dilated cardiomyopathy (DCM), 12 hypertrophic
(HCM), 2 HCM/DCM , 1 restrictive (CMR), 14 arrhythmogenic right ventric-
ular cardiomyopathy (ARVC), 1 HMC and left ventricular noncompaction.
Sanger sequencing was performed in most 4-5 frequent genes for a given phe-
notype. Fifteen mutations have been identified in sarcomeric (11 mutations) or
desmosomal (3 mutations) or lamin (1 mutation) genes. The identification of
these mutations had significant impact: assessing right diagnosis in a doubtful
case (HCM without LVH), modifying the appropriate diagnosis in another
case (HCM and not DCM), confirming a genetic disease even in the absence
of affected relatives in the family, providing guidance for genetic counselling
and predictive genetic testing in relatives in all situations. Technical, ethical
and legal issues may however be encountered and will be discussed. This
study is one of rare series of post-mortem molecular testing after SCD. Our
findings suggest the feasibility, molecular efficiency and the clinical benefit of
the approach in order to improve the management of families. Postmortem
molecular testing must take its place in the strategy of family care after SCD,
even if a cardiomyopathy is suspected at necropsy, since genetic findings pro-
vide additional information useful for the relatives. 
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This study was to assess features and outcomes of children with acute
myocarditis.
Methods: Patients <18y with acute myocarditis (proved by virology and/
or MRI and/ or complete recovery of myocardial function) were included.
Clinical data, echocardiographic parameters and outcomes were collected and
cases divided in groups I (< 2y), II (2 to 10y) and III (>10y). 
Results: 72 patients were included (1983 to 2012), 30males, aged 4.1±5.1y
(med1.5y): 43 in group I, 17 in II and 12 in III. Heart failure was present at
onset in 57(78%): 8 cardiogenic shock (12%), 30 severeHF (44%) were more
frequent in I (56%) and II (46%) than in III (17%, p< 0.0001), chest pain
(15.5%) was more frequent in III (83%). LVSF at diagnosis was 18.4±9%:
16% and 15% in groups I and II vs 30.5% in III (p= 0.0001). Aortic VTI was
11.4±5.8cm: 8cm and 11 in groups I and II vs 17 in group III (p< 0.05). Mitral
regurgitation was present in 76.5%, pericarditis in 16.4%, thromboembolic
events occurred in 5(7%), arrhythmias in 7(10%). Virus was found in
27=37.5% (1virus in 24, >in 3). Nine patients died (13%) within 2months
post-diagnosis (2days to 8.6months), 1 was transplanted (3rdmonth), 19 have
sequellae (27.5%), 40 recovered (58%), at FU= 5.5±5.6y. Inotrope was needed
in 34(47%):51%, 59% and 16% of groups I, II and III respectively
(p<0.0001). Six (8.3%, 1 in groupIII) needed mechanical circulatory support
(3ECMO, 3VAD), within day-14 from onset: 1 died on support, 5 were
